Alison Long
Director/Board Member bij TAYSHA GENE THERAPIES, INC.
Vermogen: - $ op 31-03-2024
Profiel
Alison Long is currently a Director at Taysha Gene Therapies, Inc. She was previously the Chief Medical Officer at Kaleido Biosciences, Inc. and the Chief Medical Officer & Senior Vice President at Freeline Therapeutics Holdings Plc.
Dr. Long holds a doctorate degree from George Mason University and the University of the Witwatersrand.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 01-11-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Alison Long
| Bedrijven | Functie | Begin |
|---|---|---|
| TAYSHA GENE THERAPIES, INC. | Director/Board Member | 01-11-2023 |
Eerdere bekende functies van Alison Long
| Bedrijven | Functie | Einde |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 01-06-2022 |
| FREELINE THERAPEUTICS HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 01-11-2021 |
Opleiding van Alison Long
| George Mason University | Doctorate Degree |
| University of the Witwatersrand | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| KALEIDO BIOSCIENCES, INC. | Health Technology |
| TAYSHA GENE THERAPIES, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Freeline Therapeutics Holdings Plc
 Freeline Therapeutics Holdings Plc BiotechnologyHealth Technology Freeline Therapeutics Holdings Plc engages in the business of developing and commercializing gene therapies. It also develops gene therapies for bleeding and other debilitating disorders. The company was founded by Markus Hörer and Amit Chunilal Nathwani in 2015 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
